Clinical Trial Update: Levetiracetam Three Times Daily in Epilepsy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating thrice-daily Levetiracetam for epilepsy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: Waad Alkathiri | Conditions: Epilepsy | Phase 3 | Status: RECRUITING